Showing 341 - 360 results of 47,344 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 16 ((nn decrease) OR (a decrease)) ))', query time: 0.94s Refine Results
  1. 341
  2. 342
  3. 343
  4. 344
  5. 345
  6. 346
  7. 347
  8. 348

    S1 File - by Yonghui Zhang (279832)

    Published 2024
    “…The CSPM, driven by the optimized CSPs, is then evaluated against two independent phenological datasets from Exp. 2 and Exp. 4 described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0302098#pone.0302098.t002" target="_blank">Table 2</a>. Root means square error (RMSE) (mean absolute error (MAE), coefficient of determination (R<sup>2</sup>), and Nash Sutcliffe model efficiency (NSE)) are 15.50 (14.63, 0.96, 0.42), 4.76 (3.92, 0.97, 0.95), 4.69 (3.72, 0.98, 0.95), 3.91 (3.40, 0.99, 0.96) and 12.54 (11.67, 0.95, 0.60), 5.07 (4.61, 0.98, 0.93), 4.97 (4.28, 0.97, 0.94), 4.58 (4.02, 0.98, 0.95) for using one, two, three, and four observed phenological stages in the CSPs estimation. …”
  9. 349
  10. 350
  11. 351
  12. 352
  13. 353
  14. 354
  15. 355
  16. 356
  17. 357

    PARP-1 inhibition decreases atherogenic index in ApoE<sup>−/−</sup> mice on HF diet for 16 weeks. by Chetan P. Hans (195965)

    Published 2009
    “…<p>Lipid profile data of 4 h starved mice shows that PARP-1 inhibition significantly increased HDL-cholesterol and total cholesterol in ApoE<sup>−/−</sup> mice on regular diet (4A and 4C). After feeding HF diet for 16 weeks, total and LDL-cholesterol increased dramatically in ApoE<sup>−/−</sup> mice. …”
  18. 358

    Supplementary Material for: Decreased Systemic Levels of Endocan-1 and CXCL16 in Psoriasis Are Restored following Narrowband UVB Treatment by Sigurdardottir G. (5710955)

    Published 2018
    “…<b><i>Methods:</i></b> The levels of 17 potential biomarkers with an association with cardiovascular risk were quantitated in plasma from 37 age- and gender-matched psoriasis patients and controls at baseline and in 21 psoriasis patients after 12 weeks of NB-UVB treatment to identify a systemic treatment response. <b><i>Results:</i></b> We identified the mediators endocan-1, CXCL16, and sVEGFR1, which were systemically decreased in psoriasis at baseline, as well as FABP3, FABP4, and sIL-1R1, which showed normal baseline levels. …”
  19. 359
  20. 360